- Home
- TLPH vs VIVO Comparison
TLPH vs VIVO Comparison
Compare TLPH & VIVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
HOLD
Current Price
$0.81
Company Overview
Basic Information| Metric | TLPH | VIVO |
|---|---|---|
| Founded | 2005 | 2014 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.3M | 37.5M |
| IPO Year | 2010 | N/A |
Fundamental Metrics
Financial Performance| Metric | TLPH | VIVO |
|---|---|---|
| Price | $0.81 | $6.18 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 138.9K | ★ 1.8M |
| Earning Date | 05-13-2026 | 05-23-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $2,151,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.38 | $1.97 |
| 52 Week High | $1.57 | $5.60 |
Technical Indicators
Market Signals| Indicator | TLPH | VIVO |
|---|---|---|
| Relative Strength Index (RSI) | 45.75 | 72.56 |
| Support Level | $0.73 | $2.87 |
| Resistance Level | $0.87 | N/A |
| Average True Range (ATR) | 0.06 | 0.73 |
| MACD | -0.01 | 0.15 |
| Stochastic Oscillator | 20.88 | 96.80 |
Price Performance
Historical Comparison TLPH
VIVO
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.